BUPARVAQUONE
| PHARMACOPEA | INHOUSE |
|---|---|
| CAS NUMBER | 88426-33-9 |
| THERAPEUTIC USE | ANTIPROTOZOAL |
| PACKING | 25kgs HDPE DRUMS |
| SOURCE / ROUTE OF PRODUCT | SYNTHETIC |
| DESCRIPTION / PHYSICAL APPEARANCE | Yellow coloured powder |
| MOLECULAR FORMULA | C21H26O3 |
Summary:
Buparvaquone is a naphthoquinone antiprotozoal drug. It is a promising compound for the therapy and prophylaxis of all forms of theileriosis. Buparvaquone has been shown to have anti-leishmanial activity in vitro. It can be used to treat bovine East Coast fever protozoa in vitro, along with the only other substance known – Peganum harmala. It is the only really effective commercial therapeutic product against bovine theileriosisUse in VET:
Buparvaquone is an antiprotozoal drug used Camel, Cattle, Sheet and Goat.Use In :
InjectionsChemical Structure:
Reference:Wikipedia, National Library of medicine and Pharmacopoeial books.
